XML 65 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Major Product Category by Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 187,016 $ 118,070 $ 362,220 $ 224,488
Change 58.40%   61.40%  
Bone Growth Therapies [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 52,662 47,765 $ 100,376 89,713
Change 10.30%   11.90%  
Spinal Implants, Biologics, and Enabling Technologies [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 105,314 43,017 $ 206,806 83,724
Change 144.80%   147.00%  
Global Spine [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 157,976 90,782 $ 307,182 173,437
Change 74.00%   77.10%  
Global Orthopedics [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 29,040 $ 27,288 $ 55,038 $ 51,051
Change 6.40%   7.80%